Researchers at Stanford have developed an IL-7–conjugated lipid nanoparticle (LNP) platform designed to substantially improve mRNA delivery to T cells for direct in vivo T-cell engineering.
Stanford researchers at the Ferrara Lab have developed a method to select receptor targets for molecular imaging and therapies by applying spatial transcriptomics, proteomics, and machine learning.
Stanford researchers at the Ferrara Lab have designed an ultra-fast standing device for breast ultrasound which is more comfortable than current designs and has higher resolution.
Ultrasound technology is a safe, high-resolution, and cost-efficient tool for imaging. Other modalities, such as MRI or CT, may require the use of anesthesia. This makes it difficult to image pediatric patients and patients sensitive to anesthesia.